Anđelić-Jelić, Marina

Link to this page

Authority KeyName Variants
79eed3ed-8193-4713-b9ca-af4c2f401b90
  • Anđelić-Jelić, Marina (4)
Projects

Author's Bibliography

Reduction of body weight by therapy with H2 receptor antagonists

Pudar, Georgina; Dapčević, Branka M.; Anđelić-Jelić, Marina; Svorcan, Petar N.; Branković, Andrijana

(Japan Endocrine Soc, Kyoto, 2010)

TY  - CONF
AU  - Pudar, Georgina
AU  - Dapčević, Branka M.
AU  - Anđelić-Jelić, Marina
AU  - Svorcan, Petar N.
AU  - Branković, Andrijana
PY  - 2010
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1547
PB  - Japan Endocrine Soc, Kyoto
C3  - Endocrine Journal
T1  - Reduction of body weight by therapy with H2 receptor antagonists
VL  - 57
SP  - S429
EP  - S429
UR  - https://hdl.handle.net/21.15107/rcub_smile_1547
ER  - 
@conference{
author = "Pudar, Georgina and Dapčević, Branka M. and Anđelić-Jelić, Marina and Svorcan, Petar N. and Branković, Andrijana",
year = "2010",
publisher = "Japan Endocrine Soc, Kyoto",
journal = "Endocrine Journal",
title = "Reduction of body weight by therapy with H2 receptor antagonists",
volume = "57",
pages = "S429-S429",
url = "https://hdl.handle.net/21.15107/rcub_smile_1547"
}
Pudar, G., Dapčević, B. M., Anđelić-Jelić, M., Svorcan, P. N.,& Branković, A.. (2010). Reduction of body weight by therapy with H2 receptor antagonists. in Endocrine Journal
Japan Endocrine Soc, Kyoto., 57, S429-S429.
https://hdl.handle.net/21.15107/rcub_smile_1547
Pudar G, Dapčević BM, Anđelić-Jelić M, Svorcan PN, Branković A. Reduction of body weight by therapy with H2 receptor antagonists. in Endocrine Journal. 2010;57:S429-S429.
https://hdl.handle.net/21.15107/rcub_smile_1547 .
Pudar, Georgina, Dapčević, Branka M., Anđelić-Jelić, Marina, Svorcan, Petar N., Branković, Andrijana, "Reduction of body weight by therapy with H2 receptor antagonists" in Endocrine Journal, 57 (2010):S429-S429,
https://hdl.handle.net/21.15107/rcub_smile_1547 .

The effects of decreased gastric secretion on treatment of obesity

Pudar, Georgina; Dapčević, B.; Anđelić-Jelić, Marina; Svorcan, P.; Branković, Andrijana

(Springer, New York, 2009)

TY  - CONF
AU  - Pudar, Georgina
AU  - Dapčević, B.
AU  - Anđelić-Jelić, Marina
AU  - Svorcan, P.
AU  - Branković, Andrijana
PY  - 2009
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1464
PB  - Springer, New York
C3  - Diabetologia
T1  - The effects of decreased gastric secretion on treatment of obesity
VL  - 52
SP  - S275
EP  - S275
UR  - https://hdl.handle.net/21.15107/rcub_smile_1464
ER  - 
@conference{
author = "Pudar, Georgina and Dapčević, B. and Anđelić-Jelić, Marina and Svorcan, P. and Branković, Andrijana",
year = "2009",
publisher = "Springer, New York",
journal = "Diabetologia",
title = "The effects of decreased gastric secretion on treatment of obesity",
volume = "52",
pages = "S275-S275",
url = "https://hdl.handle.net/21.15107/rcub_smile_1464"
}
Pudar, G., Dapčević, B., Anđelić-Jelić, M., Svorcan, P.,& Branković, A.. (2009). The effects of decreased gastric secretion on treatment of obesity. in Diabetologia
Springer, New York., 52, S275-S275.
https://hdl.handle.net/21.15107/rcub_smile_1464
Pudar G, Dapčević B, Anđelić-Jelić M, Svorcan P, Branković A. The effects of decreased gastric secretion on treatment of obesity. in Diabetologia. 2009;52:S275-S275.
https://hdl.handle.net/21.15107/rcub_smile_1464 .
Pudar, Georgina, Dapčević, B., Anđelić-Jelić, Marina, Svorcan, P., Branković, Andrijana, "The effects of decreased gastric secretion on treatment of obesity" in Diabetologia, 52 (2009):S275-S275,
https://hdl.handle.net/21.15107/rcub_smile_1464 .

The CFTR M470V gene variant as a potential modifier of COPD severity: Study of Serbian population

Stanković, Marija; Nikolić, Aleksandra; Divac, Aleksandra; Tomović, Andrija; Petrović-Stanojević, Nataša; Anđelić-Jelić, Marina; Dopuđa-Pantić, Vesna; Surlan, Mirjana; Vujicić, Ivan; Ponomarev, Dimitrije; Mitic-Milikić, Marija; Kusić, Jelena; Radojković, Dragica

(Mary Ann Liebert, Inc, New Rochelle, 2008)

TY  - JOUR
AU  - Stanković, Marija
AU  - Nikolić, Aleksandra
AU  - Divac, Aleksandra
AU  - Tomović, Andrija
AU  - Petrović-Stanojević, Nataša
AU  - Anđelić-Jelić, Marina
AU  - Dopuđa-Pantić, Vesna
AU  - Surlan, Mirjana
AU  - Vujicić, Ivan
AU  - Ponomarev, Dimitrije
AU  - Mitic-Milikić, Marija
AU  - Kusić, Jelena
AU  - Radojković, Dragica
PY  - 2008
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1452
AB  - Chronic obstructive pulmonary disease (COPD) is a complex disease influenced by genetic and environmental factors. Cystic fibrosis transmembrane conductance regulator (CFTR) protein is an important component of the lung tissue homeostasis, involved in the regulation of the rate of mucociliary clearance. As it is known that certain CFTR variants have consequences on the function of CFTR protein, the aim of this study was to examine the possible role of F508del, M470V, Tn locus, and R75Q variants in COPD development and modulation. Total number of 86 COPD patients and 102 control subjects were included in the study. Possible association between COPD susceptibility, severity, and onset of the disease and allele or genotype of four analyzed CFTR variants was examined. No associations were detected between COPD development, onset of the disease and tested CFTR alleles and genotypes. However, VV470 genotype was associated with mild/moderate COPD stages in comparison to severe/very severe ones (OR = 0.29, 95% CI = 0.11-0.80, p = 0.016). Our study showed that patients with VV470 genotype had a 3.4-fold decreased risk for the appearance of severe/very severe COPD symptoms, and the obtained results indicate that this genotype may have a protective role. These results also suggest the importance of studying CFTR gene as a modifier of this disease.
PB  - Mary Ann Liebert, Inc, New Rochelle
T2  - Genetic Testing
T1  - The CFTR M470V gene variant as a potential modifier of COPD severity: Study of Serbian population
VL  - 12
IS  - 3
SP  - 357
EP  - 362
DO  - 10.1089/gte.2007.0069
ER  - 
@article{
author = "Stanković, Marija and Nikolić, Aleksandra and Divac, Aleksandra and Tomović, Andrija and Petrović-Stanojević, Nataša and Anđelić-Jelić, Marina and Dopuđa-Pantić, Vesna and Surlan, Mirjana and Vujicić, Ivan and Ponomarev, Dimitrije and Mitic-Milikić, Marija and Kusić, Jelena and Radojković, Dragica",
year = "2008",
abstract = "Chronic obstructive pulmonary disease (COPD) is a complex disease influenced by genetic and environmental factors. Cystic fibrosis transmembrane conductance regulator (CFTR) protein is an important component of the lung tissue homeostasis, involved in the regulation of the rate of mucociliary clearance. As it is known that certain CFTR variants have consequences on the function of CFTR protein, the aim of this study was to examine the possible role of F508del, M470V, Tn locus, and R75Q variants in COPD development and modulation. Total number of 86 COPD patients and 102 control subjects were included in the study. Possible association between COPD susceptibility, severity, and onset of the disease and allele or genotype of four analyzed CFTR variants was examined. No associations were detected between COPD development, onset of the disease and tested CFTR alleles and genotypes. However, VV470 genotype was associated with mild/moderate COPD stages in comparison to severe/very severe ones (OR = 0.29, 95% CI = 0.11-0.80, p = 0.016). Our study showed that patients with VV470 genotype had a 3.4-fold decreased risk for the appearance of severe/very severe COPD symptoms, and the obtained results indicate that this genotype may have a protective role. These results also suggest the importance of studying CFTR gene as a modifier of this disease.",
publisher = "Mary Ann Liebert, Inc, New Rochelle",
journal = "Genetic Testing",
title = "The CFTR M470V gene variant as a potential modifier of COPD severity: Study of Serbian population",
volume = "12",
number = "3",
pages = "357-362",
doi = "10.1089/gte.2007.0069"
}
Stanković, M., Nikolić, A., Divac, A., Tomović, A., Petrović-Stanojević, N., Anđelić-Jelić, M., Dopuđa-Pantić, V., Surlan, M., Vujicić, I., Ponomarev, D., Mitic-Milikić, M., Kusić, J.,& Radojković, D.. (2008). The CFTR M470V gene variant as a potential modifier of COPD severity: Study of Serbian population. in Genetic Testing
Mary Ann Liebert, Inc, New Rochelle., 12(3), 357-362.
https://doi.org/10.1089/gte.2007.0069
Stanković M, Nikolić A, Divac A, Tomović A, Petrović-Stanojević N, Anđelić-Jelić M, Dopuđa-Pantić V, Surlan M, Vujicić I, Ponomarev D, Mitic-Milikić M, Kusić J, Radojković D. The CFTR M470V gene variant as a potential modifier of COPD severity: Study of Serbian population. in Genetic Testing. 2008;12(3):357-362.
doi:10.1089/gte.2007.0069 .
Stanković, Marija, Nikolić, Aleksandra, Divac, Aleksandra, Tomović, Andrija, Petrović-Stanojević, Nataša, Anđelić-Jelić, Marina, Dopuđa-Pantić, Vesna, Surlan, Mirjana, Vujicić, Ivan, Ponomarev, Dimitrije, Mitic-Milikić, Marija, Kusić, Jelena, Radojković, Dragica, "The CFTR M470V gene variant as a potential modifier of COPD severity: Study of Serbian population" in Genetic Testing, 12, no. 3 (2008):357-362,
https://doi.org/10.1089/gte.2007.0069 . .
4
15
12
15

Polymorphism MTHFR C677T in patients with chronic pancreatitis and pancreatic cancer

Nikolić, A.; Nisević, I; Dinić, J.; Lukić, S.; Anđelić-Jelić, Marina; Petrović-Stanojević, Nataša; Đorđević, V; Rakićević, Ljiljana; Ugljesić, M.; Radojković, Dragica

(Oxford Univ Press, Oxford, 2007)

TY  - CONF
AU  - Nikolić, A.
AU  - Nisević, I
AU  - Dinić, J.
AU  - Lukić, S.
AU  - Anđelić-Jelić, Marina
AU  - Petrović-Stanojević, Nataša
AU  - Đorđević, V
AU  - Rakićević, Ljiljana
AU  - Ugljesić, M.
AU  - Radojković, Dragica
PY  - 2007
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1333
PB  - Oxford Univ Press, Oxford
C3  - Annals of Oncology
T1  - Polymorphism MTHFR C677T in patients with chronic pancreatitis and pancreatic cancer
VL  - 18
SP  - VII64
EP  - VII65
UR  - https://hdl.handle.net/21.15107/rcub_smile_1333
ER  - 
@conference{
author = "Nikolić, A. and Nisević, I and Dinić, J. and Lukić, S. and Anđelić-Jelić, Marina and Petrović-Stanojević, Nataša and Đorđević, V and Rakićević, Ljiljana and Ugljesić, M. and Radojković, Dragica",
year = "2007",
publisher = "Oxford Univ Press, Oxford",
journal = "Annals of Oncology",
title = "Polymorphism MTHFR C677T in patients with chronic pancreatitis and pancreatic cancer",
volume = "18",
pages = "VII64-VII65",
url = "https://hdl.handle.net/21.15107/rcub_smile_1333"
}
Nikolić, A., Nisević, I., Dinić, J., Lukić, S., Anđelić-Jelić, M., Petrović-Stanojević, N., Đorđević, V., Rakićević, L., Ugljesić, M.,& Radojković, D.. (2007). Polymorphism MTHFR C677T in patients with chronic pancreatitis and pancreatic cancer. in Annals of Oncology
Oxford Univ Press, Oxford., 18, VII64-VII65.
https://hdl.handle.net/21.15107/rcub_smile_1333
Nikolić A, Nisević I, Dinić J, Lukić S, Anđelić-Jelić M, Petrović-Stanojević N, Đorđević V, Rakićević L, Ugljesić M, Radojković D. Polymorphism MTHFR C677T in patients with chronic pancreatitis and pancreatic cancer. in Annals of Oncology. 2007;18:VII64-VII65.
https://hdl.handle.net/21.15107/rcub_smile_1333 .
Nikolić, A., Nisević, I, Dinić, J., Lukić, S., Anđelić-Jelić, Marina, Petrović-Stanojević, Nataša, Đorđević, V, Rakićević, Ljiljana, Ugljesić, M., Radojković, Dragica, "Polymorphism MTHFR C677T in patients with chronic pancreatitis and pancreatic cancer" in Annals of Oncology, 18 (2007):VII64-VII65,
https://hdl.handle.net/21.15107/rcub_smile_1333 .